ACB — Aurora Cannabis Income Statement
0.000.00%
- CA$366.45m
- CA$398.19m
- CA$270.28m
- 32
- 85
- 34
- 49
Annual income statement for Aurora Cannabis, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
R2020 June 30th | 2021 June 30th | 2022 June 30th | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 9 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 269 | 245 | 221 | 174 | 270 |
Cost of Revenue | |||||
Gross Profit | -145 | -131 | -97.4 | -30.8 | -3.13 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,667 | 888 | 1,930 | 373 | 354 |
Operating Profit | -3,398 | -642 | -1,708 | -200 | -83.6 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3,340 | -700 | -1,720 | -198 | -59.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3,257 | -693 | -1,718 | -183 | -59 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3,283 | -694 | -1,718 | -198 | -65.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3,283 | -694 | -1,718 | -198 | -65.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -145 | -31.5 | -38.7 | -5.04 | -2.68 |
Dividends per Share |